Phosphorylation of TFCP2L1 by CDK1 is required for stem cell pluripotency and bladder carcinogenesis

Author:

Heo Jinbeom12,Noh Byeong‐Joo3,Lee Seungun12,Lee Hye‐Yeon12,Kim YongHwan12,Lim Jisun12,Ju Hyein12,Yu Hwan Yeul12,Ryu Chae‐Min12,Lee Peter CW1,Jeong Hwangkyo4,Oh Yumi4,Kim Kyunggon4,Kim Sang‐Yeob4,Son Jaekyoung1,Hong Bumsik5,Kim Jong Soo6,Cho Yong Mee7ORCID,Shin Dong‐Myung12ORCID

Affiliation:

1. Department of Biomedical Sciences Asan Medical Center University of Ulsan College of Medicine Seoul Korea

2. Department of Physiology University of Ulsan College of Medicine Seoul Korea

3. Department of Pathology Gangneung Asan Hospital University of Ulsan College of Medicine Gangneung Korea

4. Department of Convergence Medicine Asan Medical Center University of Ulsan College of Medicine Seoul Korea

5. Department of Urology Asan Medical Center University of Ulsan College of Medicine Seoul Korea

6. Department of Stem Cell Biology School of Medicine Konkuk University Seoul Korea

7. Department of Pathology Asan Medical Center University of Ulsan College of Medicine Seoul Korea

Funder

National Research Foundation of Korea

Ministry of Health and Welfare

Ministry of Education

Publisher

EMBO

Subject

Molecular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3